Effect of dacarbacine (DTIC) on tumor growth in patients with metastatic neuroendocrine gastroenteropancreatic (GEP) tumors.

被引：1
|
作者：
Sprenger, A
Wied, M
Mueller, HH
Klose, K
Arnold, R
机构：
[1] Dept Internal Med, Marburg, Germany
[2] Dept Radiol, Marburg, Germany
[3] Univ Marburg, Marburg, Germany
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)84728-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
3290
引用
收藏
页码：A647 / A647
页数：1
相关论文
共 50 条
  • [21] The diagnosis and medical management of gastroenteropancreatic neuroendocrine tumors (GEP NET)
    Kos-Kudla, Beata
    Foltyn, Wanda
    Zemczak, Anna
    Marek, Bogdan
    Sieminska, Lucyna
    Kajdaniuk, Dariusz
    [J]. PRZEGLAD GASTROENTEROLOGICZNY, 2006, 1 (01): : 3 - 9
  • [22] Cutaneous Metastasis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-Nets)
    Dhingra, Rohit
    Tse, Julie Y.
    Saif, Muhammad Wasif
    [J]. JOURNAL OF THE PANCREAS, 2018, 19 (05): : 258 - 260
  • [23] Surgery for neuroendocrine tumors of the gastroenteropancreatic system (GEP-NET)
    Goretzki, P. E.
    Starke, A.
    Akca, A.
    Lammers, B. J.
    [J]. INTERNIST, 2012, 53 (02): : 152 - 160
  • [24] Lymph node metastases in the prognosis of gastroenteropancreatic neuroendocrine tumors.
    Martin, Jacob Andrew
    Wisnivesky, Juan P.
    Kim, Michelle Kang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [25] The CLARINET study: Assessing the effect of lanreotide autogel on tumor progression-free survival in patients with nonfunctioning gastroenteropancreatic neuroendocrine tumors.
    Delavault, Patrick
    Caplin, Martyn E.
    Liyange, Nilani
    Blumberg, Joelle
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [26] Gastroenteropancreatic neuroendocrine tumors. Diagnosis and therapy in nuclear medicine
    Haug, A. R.
    Bartenstein, P.
    [J]. INTERNIST, 2012, 53 (02): : 161 - 166
  • [27] Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs)
    Inbal Uri
    Simona Grozinsky-Glasberg
    [J]. Clinical Diabetes and Endocrinology, 4 (1):
  • [28] Octreotide use in patients with metastatic pancreatic neuroendocrine tumors.
    Cheema, A.
    Weber, J.
    Kvols, L. K.
    Strosberg, J. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Identification of primary tumors in patients presenting with metastatic gastroenteropancreatic neuroendocrine tumors DISCUSSION
    Kuetgen, Xavier
    Keck, Kendall. J.
    Lairmore, Terry
    Evans, Douglas
    Fraker, Douglas R.
    [J]. SURGERY, 2017, 161 (01) : 278 - 279
  • [30] mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
    Zanini, Sara
    Renzi, Serena
    Giovinazzo, Francesco
    Bermano, Giovanna
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
12345